Save
Linking the anti-inflammatory and anticoagulant properties, the natural inhibitor EcTI impairs the physiopathological aspects of thrombosis
ISTH Academy, Bruno Salu, 263793
ADAMTS13 levels correlate with Renal and Inflammatory Markers in Mice with Type 1 Diabetes Mellitus and Nephropathy
ISTH Academy, Michelle Teodoro Alves, 263794
Evaluation of oral anticoagulation-associated intracerebral hemorrhage induced by collagenase VII-S in rats
ISTH Academy, Roberto Fonseca, 263795
EVALUATION OF TWO EXPERIMENTAL MODELS OF DEEP VENOUS THROMBOSIS IN RATS
ISTH Academy, Neiva Pereira Paim, 263796
Clinical implications of antivenom failures to neutralise coagulotoxicity of African snake venoms
ISTH Academy, Bryan Fry, 263811
The clinical implications of the differential coagulopathic effects of Asian pit viper snake venoms
ISTH Academy, Jordan Debono, 263812
An overview of coagulation disturbances caused by Australian Elapid snake venoms
ISTH Academy, Christina Zdenek, 263813
Coagulotoxic activity in venoms from coral snakes of the Americas (genus: Micrurus)
ISTH Academy, Daniel Dashevsky, 263814
Polyphosphate, Zn2+ and high-molecular-weight kininogen modulate individual reactions of the contact pathway of blood clotting
ISTH Academy, Yuqi Wang, 263829
Binding of activated factor XI to the platelet surface facilitates the activation of factor IX
ISTH Academy, Stephanie Elena Reitsma, 263830
Role of N-glycosylation on the secretion, plasma levels and function of Factor XII: results from patients with congenital disorders of glycosylation and a recombinant model
ISTH Academy, Maria Eugenia de la Morena-Barrio, 263831
A novel antithrombotic coating for blood-contacting medical devices
ISTH Academy, Lucia Musumeci, 263832
Interpretation of Maximum Absorbance Data Obtained from Turbidimetry in Plasma Samples
ISTH Academy, Marlien Pieters, 263846
The Comparability Evaluation and Improvement Study of Fibrinogen Measurement
ISTH Academy, Mingting Peng, 263847
Fibrin γ-chain cross-linking increases clot elastic modulus and protects against embolization as demonstrated in a new genetically modified murine model
ISTH Academy, Robert Ariëns, 263848
Genetic abnormalities of Japanese patient with symptomatic- and asymptomatic-dysfibrinogenemia
ISTH Academy, Shogo Tamura, 263849
Conditions associated with low tPA activity are prevalent among patients with schizophrenia or schzoaffective disorder
ISTH Academy, Silvia Hoirisch-Clapauch, 263862
Temporal distribution pattern of tissue-type plasminogen activator (tPA) activity in the central nervous system (CNS) delivered via the intranasal route: implications for targeted delivery of tPA to the CNS
ISTH Academy, Fiona McCutcheon, 263863
Plasma PAI-1 and tPA contents under ischemic stroke with diabetes mellitus combination
ISTH Academy, Olha Kravchenko, 263864
Pharmacokinetic study of FⅧ in Chinese boys with hemophilia
ISTH Academy, Huang Kun, 263880
Quality of Electronic Treatment Records in Patients with Hemophilia and von Willebrand Disease
ISTH Academy, Andreas Tiede, 263881
Efficacy of short-term individualized prophylaxis guided by PK and joint evaluation in Chinese adult patients with severe hemophilia A
ISTH Academy, Xueyan Sun, 263882
Management of a paediatric patient with mild haemophilia A with High Count T-Cell acute lymphoblastic leukaemia (ALL)
ISTH Academy, Alice Wilkinson, 263896
A Retrospective, Observational Study using Specialty Pharmacy data of Rurioctocog Alfa Pegol Use in the United States
ISTH Academy, Maureen Watt, 263897
Final data from the Italian Registry on intracranial haemorrhage in haemophilia patients: EMO.REC Registry (2009-2018)
ISTH Academy, Ezio Zanon, 263898
Low dose prophylaxis regimen in children and young adults- Three years experience from Kerala, India
ISTH Academy, Neeraj Sidharthan, 263912
Marked Improvement of Analytical Resolution of Low-Level Coagulation Factor VIII and IX Measurement by Applying Model Based Analysis of Clot Waveform
ISTH Academy, Song Jaewoo, 263913
Real-world Study of Physician Practice Patterns, Efficacy and Safety of Human Cell Line-derived Recombinant Factor VIII in Adults with Hemophilia A
ISTH Academy, Haowei Sun, 263914
Efficacy and safety of rIX-FP in surgery: an update from a phase 3b extension study
ISTH Academy, Claude Négrier, 263929
HaemoValue: Development of a Set of Outcomes for Measuring Value in Persons with Haemophilia
ISTH Academy, Erna Van Balen, 263930
Adding the patient’s voice to a hemophilia-specific goal menu to facilitate Goal Attainment Scaling: a qualitative study
ISTH Academy, Michael Denne, 263931
Archeogenetics of the p.Cys38Arg variant associated with FXI deficiency: a 5,400 years old mutation identified in different southwestern European countries
ISTH Academy, Maria Eugenia de la Morena-Barrio, 263947
Congenital Factor VII deficiency: epidemiology, clinical characteristics and management. Experience of the Northern Greece Hemophilia Center
ISTH Academy, Vasileia Garypidou, 263948
Efficacy and safety of fibrinogen concentrate for treatment of bleeding, surgery or routine prophylaxis in subjects with congenital fibrinogen deficiency
ISTH Academy, Joseph Lasky, 263949
Single Centre Experience On Pediatric Rare Inherited Clotting Factor Deficiencies (RICFD) From Kingdom Of Saudi Arabia - An Impetus To Establish A National Registry
ISTH Academy, Mahasen Saleh, 263963
Generation of two HEK reporter cell lines to study localization and functional interactions of VKORC1 and VKORC1L1 in a native cell environment
ISTH Academy, Francesco Forin, 263964
Results from a Phase 3 Study of On-demand Treatment with Fibrinogen Concentrate for Acute Bleeding and Surgical Prophylaxis in Patients with Congenital Fibrinogen Deficiency
ISTH Academy, Bruce Schwartz, 263965
Investigation of the epidemiology of VWD in patients attending the Royal Hospital, Muscat, Oman
ISTH Academy, Rashid Al Ghaithi, 263980
Desmopressin plasma concentration does not correlate with VWF and FVIII response in von Willebrand disease
ISTH Academy, Jessica Heijdra, 263981
The management of patients with von Willebrand disease (VWD) undergoing surgery by using a pure plasma derived VWF is easy, efficient and safe
ISTH Academy, Jenny Goudemand, 263982
Efficacy and safety of hFVIII/VWF concentrate in a large cohort of patients with von Willebrand disease (VWD) requiring surgical procedures: the French experience
ISTH Academy, Valerie Proulle, 263996
BMI is an important determinant of VWF and FVIII levels in patients with von Willebrand disease
ISTH Academy, Ferdows Atiq, 263997
Infusion Requirements in On Demand Treatment of Bleeding Events in von Willebrand Disease (VWD): an Indirect Treatment Comparison between Recombinant von Willebrand Factor (VWF) and Plasma Derived VWF Concentrates
ISTH Academy, Björn Mellgård, 263998
DDAVP challenge test in patients with von Willebrand disease type 1 (VWD1) and low von Willebrand factor (Low VWF): analysis of 616 patients
ISTH Academy, Mara Agazzoni, 264013
The Effect of Exercise-based Cardiac Rehabilitation on Heart Rates and Oxygen Consumption in Patients with Myocardial Infarction: A Meta-Analysis
ISTH Academy, Arif Nur Akhmad, 264015
Some Haemostatic parameters, Full blood count and Relative Plasma Viscosity of blood donors in Calabar metropolis
ISTH Academy, Dorathy Chioma Okpokam, 264017
Hypofibrinogenemia: A novel long deletion of the fibrinogen beta chain causing mucocutaneous bleeding
ISTH Academy, Darintr Sosothikul, 264032
Kasabach-Merritt phenomenon in an infant: Tufted angioma or kaposiform hemangioendothelioma
ISTH Academy, Rumeysa Tuna, 264033
Impact of Hematology Involvement on Adolescents Admitted for Acute Heavy Menstrual Bleeding
ISTH Academy, Viia Anderson, 264035
Predictive Value of D-dimers in the Diagnosis of Suspected Acute Limb Deep Vein Thrombosis in Children: a Prospective Study
ISTH Academy, Leonardo Brandao, 264049
Incidence of VTE in Сhildren with Hematologic Disorders: a Monocentric Study in Russian Federation
ISTH Academy, Daria Morozova, 264050
Thromboembolism and Bleeding in Congenital Diaphragmatic Hernia
ISTH Academy, Leonardo Brandao, 264051
Evaluation Of Venous Thromboembolism In Childhood
ISTH Academy, Aylin Ayhan, 264065
Low dose anticoagulation in children with Kawasaki disease and large coronary artery aneurysms: our experience at Chandigarh, North India
ISTH Academy, Surjit Samlok, 264066
Central Venous Line Insertion in a Child with Factor VII Deficiency and Inhibitors to FVII
ISTH Academy, Dianne Marshall, 264067
Hemostatic Complications in Pediatric Extra Corporeal Membrane Oxygenation: the Role of Rotational Thromboelastometry
ISTH Academy, Joppe Drop, 264081
Congenital Protein C Deficiency: Unfamiliarity of this Condition led to Unfavorable Results in a 14 Year old Girl
ISTH Academy, Madlen Reschke, 264082
The impact of the volume of mediastinal lymphadenopathy on venous thromboembolism in children with lymphoma
ISTH Academy, Daria Fedorova, 264084
Development of an Umbilical Cord and Pediatric Plasma Bank
ISTH Academy, Helen Atkinson, 264099
Pediatric May-Thurner Syndrome - a Systematic Review
ISTH Academy, Leonardo Brandao, 264100
Pediatric Intracardiac Thrombosis : Right(venous) or Left(arterial) ?
ISTH Academy, Selin AYTAC, 264101
Altered Platelet Function in Patients with Chronic Lymphocytic Leukaemia Persists Despite Treatment with Ibrutinib or Venetoclax
ISTH Academy, Scott Russell McGregor, 264116
Anticipation of Bleeding in Aplastic Anemia using ISTH Bleeding scores and Platelet ranges: Is it Beneficial?
ISTH Academy, Naveena Fatima, 264117
Impaired health-related quality of life in patients with (suspected) congenital platelet function defects
ISTH Academy, Rolf Urbanus, 264118
The risk factors for severity of the GLATIT score during inherited platelets disorders
ISTH Academy, Reda Messaoudi, 264132
First Spanish Registry of Inherited Platelet Disorders [RETPLAC]
ISTH Academy, Jose Rivera, 264133
Identification of compound heterozygous mutations in RASGRP2 affecting platelet CalDAG-GEFI expression and function in patients with epistaxis
ISTH Academy, Guangying Sheng, 264134
PLATELET VOLUME PARAMETERS ACCORDING TO GESTATIONAL AGE
ISTH Academy, Saadet Akarsu, 264149
Immune thrombocytopenia in childhood: A 15 year single center experience
ISTH Academy, Alkistis Adramerina, 264150
Multi-level defects of the hematopoietic niche in essential thrombocythemia and the effects of Interferonα-2b on them
ISTH Academy, Ting Sun, 264151
Reinforcement of Integrin-Actin Linkages on Platelets in Response to Force
ISTH Academy, David Bark, 264166
Dependence of platelet traction forces on myosin activity and GPIb levels
ISTH Academy, Ingmar Schoen, 264167
Do donor attributes influence platelet quality following ex vivo storage?
ISTH Academy, Dianne Van Der Wal, 264168
PPAR alpha identified as a novel regulator of platelet function in vivo with possible dual regulation in atherothrombosis
ISTH Academy, Michael Holinstat, 264184
Pro-coagulant platelet formation involves ‘supramaximal’ Ca2+signalling
ISTH Academy, Nima Abbasian, 264185
Coenzyme Q10 attenuates platelet function through targeting cAMP/PKA pathway
ISTH Academy, Yan Yang, 264186
Activated platelets kill S. aureusand S. pneumoniae by FcγRIIa-independent mechanisms, which are not enhanced by Platelet factor 4/Heparin-antibodies
ISTH Academy, Martina Wolff, 264201
Inferior vena cava filters in cancer patients: Indications and outcome
ISTH Academy, Anila Rashid, 264202
A Comparison of Venous Thromboembolism (VTE) and Arterial Events between Ixazomib, Lenalidomide and Dexamthosone (ILD) and Lenalidomide and Dexamethosone (LD) chemotherapy in Multiple Myeloma: Single Centre Experience
ISTH Academy, Zara Sayar, 264203
Evaluation of outpatient management in patients with cancer-associated venous thromboembolism
ISTH Academy, Stephan Hendriks, 264218
Full Benefit Of Rivaroxaban Prophylaxis In High-Risk Ambulatory Cancer Patients: An Analysis Of All Thromboembolic Events In CASSINI
ISTH Academy, Alok Khorana, 264219
Efficacy and Safety of Rivaroxaban Thromboprophylaxis by Khorana Score Category: A Subgroup Analysis of CASSINI
ISTH Academy, Alok Khorana, 264220
Incidence of venous thromboembolism in patients with advanced stage cervico-uterine cancer
ISTH Academy, Gabriela Cesarman Maus, 264234
THE PROGNOSTIC VALUE AND CLINICAL SIGNIFICANCE OF ANTI-PHOSPHOLIPID ANTIBODIES IN PATIENTS WITH NHL
ISTH Academy, Gaurav Prakash, 264235
Venous and Arterial Thrombosis in Myeloproliferative Neoplasms
ISTH Academy, Lugyanti Sukrisman, 264236
Thromboelastometry alterations are related with multiple myeloma disease status. Results of the ROADMAP-MM-CAT study
ISTH Academy, Grigoris Gerotziafas, 264252
Efficacy outcomes and treatment pattern in patients with cancer-associated venous thromboembolism: A Korean Nationwide Venous Thromboembolism Study
ISTH Academy, Hun-Gyu Hwang, 264253
Risk and management of cancer-associated venous thromboembolism: a 10-year retrospective study in a tertiary teaching hospital in Hong Kong
ISTH Academy, Carmen Ka Man Cheung, 264254
Analysis of Bleeding Events on Prophylactic Rivaroxaban in the CASSINI Study
ISTH Academy, Gerald Soff, 264269
Risk of bleeding according to renal function in patients with venous thromboembolic disease under treatment with enoxaparin
ISTH Academy, Fernando Chuliber, 264270
Resumption of Anticoagulant Therapy After Anticoagulant-Related Bleeding: A Population-Based Cohort Study
ISTH Academy, Deborah Siegal, 264271
The Use of Direct Oral Anticoagulants in Inherited Antithrombin Deficiency
ISTH Academy, Andrew Doyle, 264287
Therapy persistence, adherence and predictors for non-adherence in patients who switched from vitamin K antagonists to direct oral anticoagulants
ISTH Academy, Myrthe M.A. Toorop, 264288
The season role in the occurrence of thromboembolic disease
ISTH Academy, Mohamed Habib Houman, 264290
Recurrence Risk According to Anticoagulant Prescribed for the Secondary Prevention of Venous Thrombosis
ISTH Academy, Neil Zakai, 264305
Efficacy and safety of apixaban for treatment of venous thromboembolism in a daily practice-based cohort
ISTH Academy, Stephan Hendriks, 264306
A single centre retrospective review of prophylactic apixaban safety and efficacy in patients after venous thromboembolism
ISTH Academy, Dominic Pepperell, 264307
The use of apixaban or rivaroxaban in patients taking calcineurin inhibitors (CNIs): a review of therapeutic levels
ISTH Academy, Rogers Hannah, 264325
First analysis of an observational, prospective, specific registry of cancer-associated thrombosis (CAT): TESEO registry
ISTH Academy, Andres Muñoz, 264327
Direct Oral Anticoagulant (DOAC) monitoring: A real world experience
ISTH Academy, Alison Slocombe, 264328

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings